These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15855537)

  • 1. Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
    Trong HN; Prunier AL; Leclercq R
    Antimicrob Agents Chemother; 2005 May; 49(5):2098-101. PubMed ID: 15855537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections.
    Iihara H; Suzuki T; Kawamura Y; Ohkusu K; Inoue Y; Zhang W; Monir Shah M; Katagiri Y; Ohashi Y; Ezaki T
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):297-303. PubMed ID: 16769192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
    Coskun-Ari FF; Bosgelmez-Tinaz G
    Eur J Med Res; 2008 Aug; 13(8):366-70. PubMed ID: 18952518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the DNA gyrA gene mutation with resistance to fluoroquinolones in Staphylococcus aureus isolated from patients].
    Fang Z; Song X; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):24-6. PubMed ID: 12501604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a high-density oligonucleotide array for characterization of grlA, grlB, gyrA and gyrB mutations in fluoroquinolone resistant Staphylococcus aureus isolates.
    Couzinet S; Yugueros J; Barras C; Visomblin N; Francois P; Lacroix B; Vernet G; Lew D; Troesch A; Schrenzel J; Jay C
    J Microbiol Methods; 2005 Feb; 60(2):275-9. PubMed ID: 15590102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.
    Kwak YG; Truong-Bolduc QC; Bin Kim H; Song KH; Kim ES; Hooper DC
    J Antimicrob Chemother; 2013 Dec; 68(12):2766-72. PubMed ID: 23928023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus.
    Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1998 Jan; 42(1):197-8. PubMed ID: 9449288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic evaluation of fluoroquinolone resistance in clinical isolates of Staphylococcus aureus in Tehran.
    Aligholi M; Mirsalehian A; Halimi S; Imaneini H; Taherikalani M; Jabalameli F; Asadollahi P; Mohajer B; Abdollahi A; Emaneini M
    Med Sci Monit; 2011 Sep; 17(9):PH71-4. PubMed ID: 21873957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.
    Kim MJ; Yun HJ; Kang JW; Kim S; Kwak JH; Choi EC
    J Antimicrob Chemother; 2003 Apr; 51(4):1011-6. PubMed ID: 12654771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the resistance of Staphylococcus aureus and the mechanisms of its resistance to fluoroquinolone].
    Lei Y; Gui X; Feng G
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):176-9. PubMed ID: 11798575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
    Yun HJ; Min YH; Jo YW; Shim MJ; Choi EC
    Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of highly fluoroquinolone-resistant and methicillin-resistant Staphylococcus aureus in domestic animals.
    Lin AE; Davies JE
    Can J Microbiol; 2007 Jul; 53(7):925-9. PubMed ID: 17898848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Nakano M; Deguchi T; Kawamura T; Yasuda M; Kimura M; Okano Y; Kawada Y
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2289-91. PubMed ID: 9333065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of 8-methoxyfluoroquinolone resistance in a clinical isolate of methicillin-resistant Staphylococcus aureus.
    Horii T; Suzuki Y; Takeshita A; Maekawa M
    Chemotherapy; 2007; 53(2):104-9. PubMed ID: 17202817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistant mechanisms in methicillin-resistant Staphylococcus aureus clinical isolates in Cairo, Egypt.
    Hashem RA; Yassin AS; Zedan HH; Amin MA
    J Infect Dev Ctries; 2013 Nov; 7(11):796-803. PubMed ID: 24240036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
    Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polymorphisms in mec genes and a new mec complex type in methicillin-resistant Staphylococcus aureus isolates obtained in rural Wisconsin.
    Shukla SK; Ramaswamy SV; Conradt J; Stemper ME; Reich R; Reed KD; Graviss EA
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3080-5. PubMed ID: 15273123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.